Antibody-mediated suppression of Vβ5.2/5.3+T cells in multiple sclerosis: Results from an MRI-monitored phase II clinical trial: Suppression of Vβ5.2/5.3+T Cells in Multiple Sclerosis
Journal article published in 2002 by
Joep Killestein,
Tomas Olsson,
Erik Wallström,
Anders Svenningsson,
Mohsen Khademi 
,
Lance D. Blumhardt,
Jan Fagius,
Jan Hillert,
Anne-Marie Landtblom,
Charlotte Edenius,
Leopold Årfors,
Frederik Barkhof,
Chris H. Polman
,
Lance D. Blumhardt,
Jan Fagius,
Jan Hillert,
Anne-Marie Landtblom,
Charlotte Edenius,
Leopold Årfors,
Frederik Barkhof,
Chris H. Polman
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 